Charles River Laboratories (CRL)
Provider of research models, nonclinical drug-development services, and manufacturing quality-control testing.
$287.20
vs last close+8.19 (+2.94%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 120.05% | 57.31M shares | |
|---|---|---|---|
| 584 holders · as of Jun 30, 2026 | |||
| Insiders | 1.10% | 524.3K shares | |
| 22 holders · as of Aug 27, 2026 | |||
| Adds to | 121.15% | ||
47.74M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 121.15%; nothing is left for Other.
13F, as of Jun 30, 2026
584 holders · 57.31M shares · 78 new positions · 273 increased · 204 reduced · 67 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 4.24M | 8.88% | +783.5K | Aug 13, 2026 |
| BlackRock, Inc. | 3.80M | 7.96% | −60.5K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 3.15M | 6.60% | −52.9K | Aug 13, 2026 |
| Invesco Ltd. | 2.98M | 6.25% | +587.5K | Aug 14, 2026 |
| Harris Associates L P | 2.24M | 4.69% | +87.8K | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 2.21M | 4.63% | −83.7K | Aug 13, 2026 |
| Allspring Global Investments Holdings, LLC | 1.91M | 3.99% | −88.1K | Aug 13, 2026 |
| State Street Corp | 1.86M | 3.91% | −9.3K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 10.20% | 4.87M | 13G | Sep 8, 2026 |
| Vanguard Capital Management | 7.38% | 3.63M | 13G | Apr 29, 2026 |
| Wellington Investment Advisors Holdings LLPincl. Wellington Management Company LLP, Wellington Management Group LLP +1 more | 7.25% | 3.74M | 13G | Nov 8, 2024 |
| BlackRock, Inc. | 6.90% | 3.52M | 13G | Apr 17, 2025 |
| Invesco Ltd. | 6.20% | 2.98M | 13G | Aug 13, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 25, 2026 | James C. Fosterdirector | Sale | 33,561 | $300.00 | 31,596 |
| Aug 19, 2026 | Shannon M. Parisottoofficer: CEVP, Disc & Safety Assessment | Sale | 2,039 | $294.12 | 4,807 |
| Aug 18, 2026 | Nancy C. Andrewsdirector | Sale | 573 | $285.24 | 1,438 |
| Aug 11, 2026 | Shannon M. Parisottoofficer: CEVP, Disc & Safety Assessment | Sale | 3,714 | $279.66 | 4,807 |
| Aug 11, 2026 | Birgit Girshickdirector, officer: Chief Executive Officer | Sale | 6,500 | $279.90 | 36,013 |
| Aug 10, 2026 | James C. Fosterdirector | Sale | 28,733 | $275.00 | 31,596 |
| Aug 6, 2026 | Michael Gunnar Knellofficer: SVP, Finance and CAO | Sale · 9 lots | 6,645 | $260.38 | 11,852 |
| Aug 6, 2026 | Victoria L. Creamerofficer: EVP & Chief People Officer | Sale | 4,179 | $259.16 | 30,051 |
| Aug 5, 2026 | Shannon M. Parisottoofficer: CEVP, Disc & Safety Assessment | Sale | 5,046 | $263.00 | 4,807 |
| Jun 29, 2026 | James C. Fosterdirector | Sale | 75,000 | $225.00 | 31,596 |
House and Senate disclosures
Not reported.